LONDON — (BUSINESS WIRE) — #insurance — AM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Rating of “a+” (Excellent) of Royal & Sun Alliance Insurance Limited (RSAI) (United Kingdom), RSA Insurance Ireland DAC (RSAI
Today, 58% of senior leadership report their organizations have fully implemented AI for network management, yet priorities differ across businesses based on risk and role profiles SANDY, Utah — (BUSINESS WIRE) — According to new research by Opengear, a
Now accepting applications for 2025 grants to accelerate innovation in tissue transplantation EDISON, N.J. — (BUSINESS WIRE) — MTF Biologics, a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, transplantation, and research, has awarded
NEW YORK — (BUSINESS WIRE) — $CROX #CROX — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Crocs, Inc. (“Crocs” or “the Company”) (NASDAQ: CROX) and
Law goes into effect requiring the ‘Do Not Flush’ symbol on baby wipes, other wet wipes not meant for flushing LANSING, Mich. — (BUSINESS WIRE) — #DoNotFlush — Starting Feb. 1, the new Michigan law requires baby wipes, surface cleaning
Rebecca W. Flemer, M.S., Historic Preservation, University of Pennsylvania, will share research from her work life with historic gardens on landscaping and gardens of the 1820’s at a special program, Saturday, Feb. 22, at 2 p.m. at the Discovery Center at Point
FARMINGDALE, N.J. — (BUSINESS WIRE) — Cherry Hill Mortgage Investment Corporation (the “Company” or “CHMI”) (NYSE: CHMI) Tuesday announced the estimated Federal income tax treatment of the Company’s 2024 distributions on its common and preferred stock, as described below. Shareholders are encouraged
SAN FRANCISCO & BEDMINSTER, N.J. — (BUSINESS WIRE) — Swander Pace Capital (“SPC”) is pleased to announce the following promotions recognizing each employee’s significant and long-term contribution to the organization. Alex Litt has been promoted to Managing Director. Alex joined
Based on DESTINY-Breast06 phase 3 trial results which showed ENHERTU demonstrated superiority versus chemotherapy with a median progression-free survival of more than one year Approval brings Daiichi Sankyo and AstraZeneca’s ENHERTU to an earlier HR positive treatment setting and broadens the patient